Keywords: ProStrakan, Kyowa Hakko, Anal fissure pain, Rectiv, Rectogesic

US FDA approves ProStrakan’s Rectiv for anal fissures pain

Article | 22 June 2011

Print This

Scotland-based ProStrakan, now a subsidiary of Japan’s Kyowa Hakko Kirin (TYO: 4151) as the result of a recently-completed $474 million ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in